Key result
The natriuretic polypeptide system has promising clinical utility as diagnostic and prognostic markers, and potential therapeutic targets, in pediatric patients with cardiac, renal, bone, and metabolic diseases.
Natriuretic peptides serve as useful diagnostic and prognostic markers for cardiovascular disease in children and offer potential therapeutic applications.
Answers are grounded in this paper and cite their sources.
Supports evaluation of natriuretic peptides in pediatric cardiorenal diagnostics; leaves open clinical adoption pending prospective trials.
PURPOSE OF REVIEW: This article reviews the genetics, biochemistry, and physiology of the natriuretic polypeptide family and their receptors; their roles in cardiac, bone, and lipid metabolism in children; and pharmacological agents that utilize the natriuretic polypeptide system. RECENT FINDINGS: Clinically, measurements of circulating levels of the natriuretic polypeptides are useful diagnostic and prognostic markers of cardiovascular disease in children. The natriuretic polypeptides also play an important role in growth and body composition. Therapeutic application of the natriuretic polypeptide system may provide new treatments for cardiac, renal, bone, and metabolic disease in children. SUMMARY: The natriuretic polypeptide system has promising clinical utility in the care of pediatric patients with cardiac, renal, bone, and metabolic disease.
No takes yet. Share an insight, caveat, or question.
Anne Lenz (2011) conducted a review in Cardiovascular, renal, bone, and metabolic disease in children. Natriuretic peptides was evaluated. The natriuretic polypeptide system has promising clinical utility as diagnostic and prognostic markers, and potential therapeutic targets, in pediatric patients with cardiac, renal, bone, and metabolic diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: